Answers are grounded in this paper and cite their sources.
Intrathecal phenol neurolysis is a treatment of last resort for specific refractory cancer pains. However, there is a paucity of evidence in the academic literature and no recent documented evidence of repeat injections on the same patient. We aim to present our experience and learning from repeat interventions on the same patient in order to further the evidence base for medical professionals managing pain in a palliative care setting.
No takes yet. Share an insight, caveat, or question.
Pallot et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: